Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent
Thyroid2016Vol. 26(3), pp. 381–389
Citations Over TimeTop 10% of 2016 papers
Trevor E. Angell, Melissa G. Lechner, Alison Smith, Sue Ellen Martin, Susan Groshen, Dennis R. Maceri, Peter Singer, Alan L. Epstein
Abstract
MDSC measurement using this flow cytometry-based assay represents a novel approach for preoperatively assessing malignancy risk and cancer extent in patients with thyroid nodules. While further validation is needed, these data suggest that MDSC assessment may serve as a useful adjunct when cytology is indeterminate, and predict tumor stage and recurrence risk in cases of thyroid cancer.
Related Papers
- → Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes(2017)75 cited
- → Application of thermography in the diagnostic investigation of thyroid nodules(2021)23 cited
- → Treatment of Thyroid Nodule(2002)
- → CT imaging features and its correlation with histopathology of thyroid nodules in children(2018)
- Management of Thyroid Nodules(2013)